Nystatin Oral Suspension recalled over manufacturing violations
- Recall date
- January 18, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- VistaPharm, Inc. recalls Nystatin Oral Suspension, USP 100,000 units per mL, a) 2 fl. oz. (60 mL), 24 bottles per case (NDC 66689-008-02), b) 16…
- Recall number
- D-0457-2017
- FDA classification
- Class II
- Brand / firm
- VistaPharm, Inc.
- Sold / distributed
- Nationwide
Why it was recalled
CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Nystatin Oral Suspension, USP 100,000 units per mL, a) 2 fl. oz. (60 mL), 24 bottles per case (NDC 66689-008-02), b) 16 fl. oz. (237 mL), 12 bottles per case (NDC 66689-008-16), Rx only, Manufactured by VistaPharm, Largo, FL 33771
Get recall alerts
Free email alert whenever VistaPharm, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: VistaPharm, Inc.